193 related articles for article (PubMed ID: 1530928)
21. Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project.
Watanabe-Ohnishi R; Low DE; McGeer A; Stevens DL; Schlievert PM; Newton D; Schwartz B; Kreiswirth B; Kotb M
J Infect Dis; 1995 Jan; 171(1):74-84. PubMed ID: 7798684
[TBL] [Abstract][Full Text] [Related]
22. Ganglioside and monosaccharide inhibition of nonspecific lymphocyte mitogenicity by group A streptococcal pyrogenic exotoxins.
Schlievert PM; Schoettle DJ; Watson DW
Infect Immun; 1980 Jan; 27(1):276-9. PubMed ID: 6987174
[TBL] [Abstract][Full Text] [Related]
23. Studies on the mechanisms of murine T cell activation by streptococcal pyrogenic exotoxin type A.
Imanishi K; Igarashi H; Uchiyama T
Jpn J Med Sci Biol; 1990 Dec; 43(6):278-9. PubMed ID: 2101162
[No Abstract] [Full Text] [Related]
24. Streptococcus pyogenes type 5 M protein is an antigen, not a superantigen, for human T cells.
Degnan B; Taylor J; Hawkes C; O'Shea U; Smith J; Robinson JH; Kehoe MA; Boylston A; Goodacre JA
Hum Immunol; 1997 Apr; 53(2):206-15. PubMed ID: 9129980
[TBL] [Abstract][Full Text] [Related]
25. Interactions between staphylococcal superantigens and human T-cell clones are predominantly but not exclusively governed by their T-cell receptor V beta usage.
Lundin KE; Brinchmann JE; Hansen T
Scand J Immunol; 1994 Apr; 39(4):387-94. PubMed ID: 8146598
[TBL] [Abstract][Full Text] [Related]
26. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).
Norrby-Teglund A; Newton D; Kotb M; Holm SE; Norgren M
Infect Immun; 1994 Dec; 62(12):5227-33. PubMed ID: 7960098
[TBL] [Abstract][Full Text] [Related]
27. Temporal relationship of cytokine release by peripheral blood mononuclear cells stimulated by the streptococcal superantigen pep M5.
Kotb M; Ohnishi H; Majumdar G; Hackett S; Bryant A; Higgins G; Stevens D
Infect Immun; 1993 Apr; 61(4):1194-201. PubMed ID: 8454323
[TBL] [Abstract][Full Text] [Related]
28. Stimulation of human T cells by microbial 'superantigens'.
Fleischer B
Immunol Res; 1991; 10(3-4):349-55. PubMed ID: 1835489
[TBL] [Abstract][Full Text] [Related]
29. Suppression of antibody response by group A streptococcal pyrogenic exotoxin and characterization of the cells involved.
Cunningham CM; Watson DW
Infect Immun; 1978 Feb; 19(2):470-6. PubMed ID: 344211
[TBL] [Abstract][Full Text] [Related]
30. Functional characterization of streptococcal pyrogenic exotoxin J, a novel superantigen.
McCormick JK; Pragman AA; Stolpa JC; Leung DY; Schlievert PM
Infect Immun; 2001 Mar; 69(3):1381-8. PubMed ID: 11179302
[TBL] [Abstract][Full Text] [Related]
31. Streptococcal pyrogenic exotoxin B-induced apoptosis in A549 cells is mediated through alpha(v)beta(3) integrin and Fas.
Tsai WH; Chang CW; Lin YS; Chuang WJ; Wu JJ; Liu CC; Tsai PJ; Lin MT
Infect Immun; 2008 Apr; 76(4):1349-57. PubMed ID: 18227168
[TBL] [Abstract][Full Text] [Related]
32. Nonspecific T-lymphocyte mitogenesis by pyrogenic exotoxins from group A streptococci and Staphylococcus aureus.
Schlievert PM; Schoettle DJ; Watson DW
Infect Immun; 1979 Sep; 25(3):1075-7. PubMed ID: 387590
[TBL] [Abstract][Full Text] [Related]
33. Separation of T-cell-stimulating activity from streptococcal M protein.
Fleischer B; Schmidt KH; Gerlach D; Köhler W
Infect Immun; 1992 May; 60(5):1767-70. PubMed ID: 1563763
[TBL] [Abstract][Full Text] [Related]
34. Superantigenicity of helper T-cell mitogen (SPM-2) isolated from culture supernatants of Streptococcus pyogenes.
Rikiishi H; Okamoto S; Sugawara S; Tamura K; Liu ZX; Kumagai K
Immunology; 1997 Jul; 91(3):406-13. PubMed ID: 9301530
[TBL] [Abstract][Full Text] [Related]
35. Tumor necrosis factor production by human T-cells stimulated with bacterial superantigens.
Imanishi K; Inada K; Akatsuka H; Gu Y; Igarashi H; Uchiyama T
Int J Immunopharmacol; 1995 Oct; 17(10):841-8. PubMed ID: 8707449
[TBL] [Abstract][Full Text] [Related]
36. Analysis of toxicity of streptococcal pyrogenic exotoxin A mutants.
Roggiani M; Stoehr JA; Leonard BA; Schlievert PM
Infect Immun; 1997 Jul; 65(7):2868-75. PubMed ID: 9199461
[TBL] [Abstract][Full Text] [Related]
37. Streptococcal superantigen-induced expansion of human tonsil T cells leads to altered T follicular helper cell phenotype, B cell death and reduced immunoglobulin release.
Davies FJ; Olme C; Lynskey NN; Turner CE; Sriskandan S
Clin Exp Immunol; 2019 Jul; 197(1):83-94. PubMed ID: 30815853
[TBL] [Abstract][Full Text] [Related]
38. Crystal structure of the streptococcal superantigen SpeI and functional role of a novel loop domain in T cell activation by group V superantigens.
Brouillard JN; Günther S; Varma AK; Gryski I; Herfst CA; Rahman AK; Leung DY; Schlievert PM; Madrenas J; Sundberg EJ; McCormick JK
J Mol Biol; 2007 Apr; 367(4):925-34. PubMed ID: 17303163
[TBL] [Abstract][Full Text] [Related]
39. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis (MAM). VIII. Selective activation of T cells expressing distinct V beta T cell receptors from various strains of mice by the "superantigen" MAM.
Cole BC; Kartchner DR; Wells DJ
J Immunol; 1990 Jan; 144(2):425-31. PubMed ID: 2136890
[TBL] [Abstract][Full Text] [Related]
40. Peripheral blood lymphocytes from psoriatic patients are hyporesponsive to beta-streptococcal superantigens.
Horiuchi N; Aiba S; Ozawa H; Sugawara S; Rikiishi H; Kumagai K; Tagami H
Br J Dermatol; 1998 Feb; 138(2):229-35. PubMed ID: 9602866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
